List of Excipients in API potassium chloride for oral solution
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing potassium chloride for oral solution
Detailed excipient profiles for potassium chloride for oral solution
Excipient focus: ANHYDROUS CITRIC ACID
potassium chloride for oral solution drug variants containing ANHYDROUS CITRIC ACID
potassium chloride for oral solution drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
potassium chloride for oral solution drug variants containing FD&C YELLOW NO. 6
potassium chloride for oral solution drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
potassium chloride for oral solution drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | potassium chloride for oral solution | 10135-819 |
| >Company | >Ingredient | >NDC |
potassium chloride for oral solution drug variants not containing GLYCERIN
Excipient focus: METHYLPARABEN
potassium chloride for oral solution drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | potassium chloride for oral solution | 10135-819 |
| >Company | >Ingredient | >NDC |
potassium chloride for oral solution drug variants not containing METHYLPARABEN
Excipient focus: ORANGE
potassium chloride for oral solution drug variants containing ORANGE
potassium chloride for oral solution drug variants not containing ORANGE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
potassium chloride for oral solution drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | potassium chloride for oral solution | 10135-819 |
| >Company | >Ingredient | >NDC |
potassium chloride for oral solution drug variants not containing PROPYLPARABEN
Excipient focus: SILICON DIOXIDE
potassium chloride for oral solution drug variants containing SILICON DIOXIDE
potassium chloride for oral solution drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | potassium chloride for oral solution | 10135-819 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
potassium chloride for oral solution drug variants containing SUCRALOSE
potassium chloride for oral solution drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
potassium chloride for oral solution drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | potassium chloride for oral solution | 10135-819 |
| >Company | >Ingredient | >NDC |
potassium chloride for oral solution drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
potassium chloride for oral solution drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | potassium chloride for oral solution | 10135-819 |
| >Company | >Ingredient | >NDC |
potassium chloride for oral solution drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch